Factor mediated gene priming in pluripotent stem cells sets the stage for lineage specification

BioEssays

Volumn 34, Issue 3, 2012, Pages 194-204

  Dillon, Niall ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Enhancer; ES cell; Priming; RNA polymerase II; Transcription

Indexed keywords

POLYCOMB GROUP PROTEIN;

CELL DIFFERENTIATION; CHROMATIN; DNA METHYLATION; DNA MODIFICATION; DNA REPLICATION; GENE ACTIVATION; GENE EXPRESSION; GENE PRIMING; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; HISTONE MODIFICATION; HUMAN; MITOSIS; MOLECULAR GENETICS; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HUMANS; PLURIPOTENT STEM CELLS; PROTEIN BINDING; PROTEIN TRANSPORT; REPRESSOR PROTEINS; SOXB1 TRANSCRIPTION FACTORS;

EID: 84857054810     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100137     Document Type: Review

References (82)

1. Evans M, Kaufman M. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154- 6.
2. Martin G. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634- 8.
3. Blair K, Wray J, Smith A. 2011. The liberation of embryonic stem cells. PLoS Genet 7: e1002019.
4. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, et al. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145- 7.
5. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663- 76.
6. Takahashi K, Tanabe K, Ohnuki M, Narita M, et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861- 72.
7. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917- 20.
8. Rougvie AE, Lis JT. 1988. The RNA polymerase II molecule at the 5′ end of the uninduced hsp70 gene of D. melanogaster is transcriptionally engaged. Cell 54: 795- 804.
9. Lee H, Kraus KW, Wolfner MF, Lis JT. 1992. DNA sequence requirements for generating paused polymerase at the start of hsp70. Genes Dev 6: 284- 95.
10. Tsukiyama T, Becker PB, Wu C. 1994. ATP-dependent nucleosome disruption at a heat-shock promoter mediated by binding of GAGA transcription factor. Nature 367: 525- 32.
11. Mason PB, Lis JT. 1997. Cooperative and competitive protein interactions at the hsp70 promoter. J Biol Chem 272: 33227- 33.
12. Lee C, Li X, Hechmer A, Eisen M, et al. 2008. NELF and GAGA factor are linked to promoter-proximal pausing at many genes in Drosophila. Mol Cell Biol 28: 3290- 300.
13. Wu C-H, Yamaguchi Y, Benjamin LR, Horvat-Gordon M, et al. 2003. NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila. Genes Dev 17: 1402- 14.
14. Desimone AM, Laney JD. 2010. Corepressor-directed preacetylation of histone h3 in promoter chromatin primes rapid transcriptional switching of cell-type-specific genes in yeast. Mol Cell Biol 30: 3342- 56.
15. Wolberger C, Vershon AK, Liu B, Johnson AD, et al. 1991. Crystal structure of a MAT alpha 2 homeodomain-operator complex suggests a general model for homeodomain-DNA interactions. Cell 67: 517- 28.
16. Johnson AD. 1995. Molecular mechanisms of cell-type determination in budding yeast. Curr Opin Genet Dev 5: 552- 8.
17. Araki Y, Fann M, Wersto R, Weng N-P. 2008. Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J Immunol 180: 8102- 8.
18. Boettiger AN, Levine M. 2009. Synchronous and stochastic patterns of gene activation in the Drosophila embryo. Science 325: 471- 3.
19. Szutorisz H, Canzonetta C, Georgiou A, Chow C-M, et al. 2005. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Mol Cell Biol 25: 1804- 20.
20. Azuara V, Perry P, Sauer S, Spivakov M, et al. 2006. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 8: 532- 8.
21. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315- 26.
22. Xu J, Pope SD, Jazirehi AR, Attema JL, et al. 2007. Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissue-specific enhancers in embryonic stem cells. Proc Natl Acad Sci USA 104: 12377- 82.
23. Szutorisz H, Dillon N. 2005. The epigenetic basis for embryonic stem cell pluripotency. BioEssays 27: 1286- 93.
24. Xu J, Watts JA, Pope SD, Gadue P, et al. 2009. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev 23: 2824- 38.
25. Liber D, Domaschenz R, Holmqvist P-H, Mazzarella L, et al. 2010. Epigenetic priming of a pre-B cell-specific enhancer through binding of Sox2 and Foxd3 at the ESC stage. Cell Stem Cell 7: 114- 26.
26. Vastenhouw NL, Zhang Y, Woods IG, Imam F, et al. 2010. Chromatin signature of embryonic pluripotency is established during genome activation. Nature 464: 922- 6.
27. Niwa H, Miyazaki J, Smith AG. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372- 6.
28. Chambers I, Smith A. 2004. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23: 7150- 60.
29. Avilion AA, Nicolis SK, Pevny LH, Perez L, et al. 2003. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126- 40.
30. Masui S, Nakatake Y, Toyooka Y, Shimosato D, et al. 2007. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9: 625- 35.
31. Smith KN, Singh AM, Dalton S. 2010. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 7: 343- 54.
32. Zhang P, Andrianakos R, Yang Y, Liu C, et al. 2010. Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J Biol Chem 285: 9180- 9.
33. Liu Y, Labosky PA. 2008. Regulation of embryonic stem cell self-renewal and pluripotency by Foxd3. Stem Cells 26: 2475- 84.
34. Lu R, Yang A, Jin Y. 2011. Dual functions of T-box 3 (Tbx3) in the control of self-renewal and extraembryonic endoderm differentiation in mouse embryonic stem cells. J Biol Chem 286: 8425- 36.
35. Yang J, Chai L, Fowles TC, Alipio Z, et al. 2008. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci USA 105: 19756- 61.
36. Kim T-K, Hemberg M, Gray JM, Costa AM, et al. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465: 182- 7.
37. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, et al. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Nat Acad Sci USA 107: 21931- 6.
38. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, et al. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470: 279- 83.
39. Ringrose L, Paro R. 2004. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 38: 413- 43.
40. Elderkin S, Maertens GN, Endoh M, Mallery DL, et al. 2007. A phosphorylated form of Mel-18 targets the Ring1B histone H2A ubiquitin ligase to chromatin. Mol Cell 28: 107- 20.
41. Maertens GN, El Messaoudi-Aubert S, Racek T, Stock JK, et al. 2009. Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus. PLoS ONE 4: e6380.
42. Margueron R, Reinberg D. 2011. The polycomb complex PRC2 and its mark in life. Nature 469: 343- 9.
43. Sparmann A, van Lohuizen M. 2006. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6: 846- 56.
44. Whitcomb SJ, Basu A, Allis CD, Bernstein E. 2007. Polycomb group proteins: an evolutionary perspective. Trends Genet 23: 494- 502.
45. Gonzalez ME, DuPrie ML, Krueger H, Merajver SD, et al. 2011. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. Cancer Res 71: 2360- 70.
46. Kottakis F, Polytarchou C, Foltopoulou P, Sanidas I, et al. 2011. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol Cell 43: 285- 98.
47. Miller T, Krogan NJ, Dover J, Erdjument-Bromage H, et al. 2001. COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Nat Acad Sci USA 98: 12902- 7.
48. Cierpicki T, Risner LE, Grembecka J, Lukasik SM, et al. 2010. Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia. Nat Struct Mol Biol 17: 62- 8.
49. Dou Y, Milne TA, Ruthenburg AJ, Lee S, et al. 2006. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 13: 713- 9.
50. Jiang H, Shukla A, Wang X, Chen W-Y, et al. 2011. Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains. Cell 144: 513- 25.
51. Boyer LA, Plath K, Zeitlinger J, Brambrink T, et al. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441: 349- 53.
52. Stock JK, Giadrossi S, Casanova M, Brookes E, et al. 2007. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol 9: 1428- 35.
53. Landeira D, Sauer S, Poot R, Dvorkina M, et al. 2010. Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA polymerase II to developmental regulators. Nat Cell Biol 12: 618- 24.
54. Fazzio TG, Huff JT, Panning B. 2008. An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134: 162- 74.
55. Mohn F, Weber M, Rebhan M, Roloff TC, et al. 2008. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 30: 755- 66.
56. Mazzarella L, Jørgensen HF, Soza-Ried J, Terry AV, et al. 2011. Embryonic stem cell-derived hemangioblasts remain epigenetically plastic and require PRC1 to prevent neural gene expression. Blood 117: 83- 7.
57. Araki Y, Wang Z, Zang C, Wood WH, et al. 2009. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 30: 912- 25.
58. Harker N, Garefalaki A, Menzel U, Ktistaki E, et al. 2011. Pre-TCR signaling and CD8 gene bivalent chromatin resolution during thymocyte development. J Immunol 186: 6368- 77.
59. Otte AP, Kwaks THJ. 2003. Gene repression by Polycomb group protein complexes: a distinct complex for every occasion? Curr Opin Genet Dev 13: 448- 54.
60. Ku M, Koche RP, Rheinbay E, Mendenhall EM, et al. 2008. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 4: e1000242.
61. Mendenhall EM, Koche RP, Truong T, Zhou VW, et al. 2010. GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet 6: e1001244.
62. Liu Y, Shao Z, Yuan G-C. 2010. Prediction of polycomb target genes in mouse embryonic stem cells. Genomics 96: 17- 26.
63. Kim H, Kang K, Kim J. 2009. AEBP2 as a potential targeting protein for polycomb repression complex PRC2. Nucleic Acids Res 37: 2940- 50.
64. Peng JC, Valouev A, Swigut T, Zhang J, et al. 2009. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139: 1290- 302.
65. Shen X, Kim W, Fujiwara Y, Simon MD, et al. 2009. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 139: 1303- 14.
66. Li G, Margueron R, Ku M, Chambon P, et al. 2010. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev 24: 368- 80.
67. Pasini D, Cloos PAC, Walfridsson J, Olsson L, et al. 2010. JARID2 regulates binding of the polycomb repressive complex 2 to target genes in ES cells. Nature 464: 306- 10.
68. Landeira D, Fisher AG. 2011. Inactive yet indispensable: the tale of Jarid2. Trends Cell Biol 21: 74- 80.
69. Patsialou A, Wilsker D, Moran E. 2005. DNA-binding properties of ARID family proteins. Nucleic Acids Res 33: 66- 80.
70. Kusunoki H, Takeuchi T, Kohno T. 2009. Solution structure of the AT-rich interaction domain of Jumonji/JARID2. Proteins 76: 1023- 8.
71. Rinn JL, Kertesz M, Wang JK, Squazzo SL, et al. 2007. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311- 23.
72. Zhao J, Sun BK, Erwin JA, Song J-J, et al. 2008. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322: 750- 6.
73. Yap KL, Li S, Muñoz-Cabello AM, Raguz S, et al. 2010. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662- 74.
74. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, et al. 2010. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30: 1956- 62.
75. Kanhere A, Viiri K, Araújo CC, Rasaiyaah J, et al. 2010. Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol Cell 38: 675- 88.
76. Voo KS, Carlone DL, Jacobsen BM, Flodin A, et al. 2000. Cloning of a mammalian transcriptional activator that binds unmethylated CpG motifs and shares a CXXC domain with DNA methyltransferase, human trithorax, and methyl-CpG binding domain protein 1. Mol Cell Biol 20: 2108- 21.
77. Lee TI, Jenner RG, Boyer LA, Guenther MG, et al. 2006. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125: 301- 13.
78. Teo AKK, Arnold SJ, Trotter MWB, Brown S, et al. 2011. Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev 25: 238- 50.
79. Loh Kyle M, Lim B. 2011. A precarious balance: pluripotency factors as lineage specifiers. Cell Stem Cell 8: 363- 9.
80. Favaro R, Valotta M, Ferri ALM, Latorre E, et al. 2009. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci 12: 1248- 56.
81. Catena R, Tiveron C, Ronchi A, Porta S, et al. 2004. Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J Biol Chem 279: 41846- 57.
82. Teng L, Mundell NA, Frist AY, Wang Q, et al. 2008. Requirement for Foxd3 in the maintenance of neural crest progenitors. Development 135: 1615- 24.